11:07 AM EDT, 03/17/2025 (MT Newswires) -- Evome Medical Technologies ( LNDZF ) was at last look on Monday up 27% after the company appointed Michael Dalsin as board chair.

Bill Garbarini will continue in the role of chief operating officer while stepping off the board of directors. The company also added Chris Heath as a new director increasing the size of the board to six from five.

The company and Dalsin plan to release a corporate update to the market before April 1.

Shares of the company were last seen up $0.020 to $0.095 on the TSX Venture Exchange.

Price: 0.10, Change: +0.02, Percent Change: +26.67